DOS Conference 2013
| April 14, 2013 | Posted by admin under 2013, Conferences |
DOS Conference 2013
Anyways, congratulations to the organizers for organizing another great show.
(38)
Name Suggestions for first conference
| April 10, 2013 | Posted by admin under Admin, Conferences |
AO Logo
AOEYECON-2013
Kindly leave your suggestions in the comments section.
Thanks and regards
Sarbjit (219)
Pupil Diameter affects aspheric IOL efficacy
| April 10, 2013 | Posted by admin under cataract, IOL, Surgery |
This retrospective review measured the effect of spherical aberration corrections by aspheric IOLs based on pupil diameter for two aspheric IOLs, the Tecnis ZCB00 and the HOYA NY-60. When pupil diameters are smaller than 3.4 mm for the Tecnis ZCB00 and 3.7 mm for the HOYA NY-60, spherical aberration correction using these aspheric IOLs was ineffective. About 10 percent of the eyes showed smaller pupil size than the minimum effective diameter under mesopic conditions and had no benefit from the aspheric IOLs.
American Journal of Ophthalmology, March 2013 (155)
AsianOphthalmology Anniversary today
| April 6, 2013 | Posted by admin under Admin |
We are into seventh year now since we started AsianOphthalmology on April 6, 2006. It has been a very interesting and enlightening journey bringing together some brilliant people, as ophthalmologists and as humans.I congratulate and thank every member of the group for being part of the group and making it worthwhile.
Regards
Sarbjit (103)
Revolving Circles : Optical Illusion – 3
| April 5, 2013 | Posted by admin under Optical Illusions |
Revolving Circles – Optical Illusion
Revolving Circles : Optical Illusion -
The two circles seem to rotate when the viewer’s head is moving back and forth while looking at the black dot.
Please leave your explanation in the comments.
Thanks
Sarbjit (105)
Optical Illusion -2 via Dr Quresh Maskati
| April 3, 2013 | Posted by admin under Optical Illusions |
(338)
Optical Illusion – 1
| March 28, 2013 | Posted by admin under Optical Illusions |
Optical Illusion
Dr Gaurav Luthra put this up on Facebook. I am putting this up in AOA so that we can have the explanations at one place. Please leave your explanations in the comments section. I’ll tag this and all such posts post under “Optical Illusions” so that they are easy to find.
Sarbjit Singh (135)
Online Ophthalmology Atlas
| March 24, 2013 | Posted by admin under Information, Smartphone Apps |
Online Atlas of Ophthalmology
Publisher’s Description – Atlas of Ophthalmology 1.0.4
The EyeAtlas app presents clinical images of virtually all eye diseases. The App is linked to the data base of the “Atlas of Ophthalmology”. In this database more than 6000 ophthalmic diagnoses and images are available, from common diseases like “Glaucoma”, or “Age related Macula degeneration (AMD)” to rare diseases like “M.Stargardt”. The ophthalmic image data base of the “Atlas of Ophthalmology” is continuously extended by newly submitted images.
The EyeAtlas content is accessible in 8 languages: English, German, Spanish, Portugese/Brasil, Russia, Arabia, partly Chinese and Japan. The language can be selected within the configuration setup of the App. The EyeAtlas app is a very useful tool for medical students, medical professionals of all facultiesand also for patients interested in medical information.
(more…) (321)
Recall of all Clinical Specialties Compounding Pharmacy products
| March 23, 2013 | Posted by admin under news, vitreo-retina |
The FDA has issued an updated alert for an expanded recall of all lots of ALL sterile products repackaged and distributed by Clinical Specialties Compounding Pharmacy (Augusta, Ga.) due to lack of sterility assurance. The recall of all sterile products is conducted in follow-up to concerns regarding practices at the site that cannot assure the sterility of the products. Until further notice, healthcare providers should stop using all sterile products distributed by Clinical Specialties Compounding Pharmacy and return them to the company.
On March 18, Clinical Specialties voluntarily recalled its Avastin (bevacizumab, Genentech, South San Francisco) unit dose syringes. The product has resulted in or potentially could result in an infection within the eye. Clinical Specialties received reports of endophthalmitis infections from physicians’ offices. This product was being used solely in an off-label use by ophthalmologists for macular degeneration and is packaged in sterile syringes distributed to doctors’ offices in Georgia, Louisiana, South Carolina, and Indiana between October 19, 2012 and March 19, 2013.
(Source: EyeWorld Weekly Update) (299)
Recent Comments